Norway Savings Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.36M | Sell |
4,469
-617
| -12% | -$630K | 2.25% | 11 |
|
|
2026
Q1 | $4.68M | Sell |
5,086
-148
| -3% | -$150K | 2.22% | 10 |
|
|
2025
Q4 | $5.62M | Buy |
5,234
+534
| +11% | +$511K | 2.6% | 9 |
|
|
2025
Q3 | $3.59M | Sell |
4,700
-143
| -3% | -$106K | 1.73% | 15 |
|
|
2025
Q2 | $3.78M | Sell |
4,843
-129
| -3% | -$100K | 1.94% | 14 |
|
|
2025
Q1 | $4.11M | Sell |
4,972
-249
| -5% | -$207K | 2.34% | 11 |
|
|
2024
Q4 | $4.03M | Sell |
5,221
-95
| -2% | -$78.7K | 2.23% | 10 |
|
|
2024
Q3 | $4.71M | Sell |
5,316
-167
| -3% | -$150K | 2.55% | 8 |
|
|
2024
Q2 | $4.96M | Buy |
5,483
+51
| +0.9% | +$40.8K | 2.83% | 7 |
|
|
2024
Q1 | $4.23M | Sell |
5,432
-530
| -9% | -$377K | 1.76% | 13 |
|
|
2023
Q4 | $3.48M | Sell |
5,962
-442
| -7% | -$258K | 1.54% | 14 |
|
|
2023
Q3 | $3.44M | Buy |
+6,404
| New | +$3.3M | 1.7% | 13 |
|
|
2023
Q2 | – | Sell |
-7,427
| Closed | -$2.55M | – | 134 |
|
|
2023
Q1 | $2.55M | Sell |
7,427
-170
| -2% | -$57.3K | 1.29% | 22 |
|
|
2022
Q4 | $2.78M | Sell |
7,597
-524
| -6% | -$186K | 1.41% | 18 |
|
|
2022
Q3 | $2.63M | Sell |
8,121
-350
| -4% | -$111K | 1.43% | 14 |
|
|
2022
Q2 | $2.75M | Sell |
8,471
-155
| -2% | -$46.5K | 1.42% | 17 |
|
|
2022
Q1 | $2.47M | Buy |
8,626
+382
| +5% | +$98.3K | 1.12% | 27 |
|
|
2021
Q4 | $2.28M | Sell |
8,244
-117
| -1% | -$29.7K | 1% | 31 |
|
|
2021
Q3 | $1.93M | Buy |
8,361
+245
| +3% | +$60.5K | 0.91% | 36 |
|
|
2021
Q2 | $1.86M | Buy |
8,116
+285
| +4% | +$57.2K | 0.91% | 38 |
|
|
2021
Q1 | $1.46M | Buy |
7,831
+405
| +5% | +$79.2K | 0.77% | 42 |
|
|
2020
Q4 | $1.25M | Buy |
7,426
+330
| +5% | +$49.3K | 0.72% | 47 |
|
|
2020
Q3 | $1.05M | Sell |
7,096
-5
| -0.1% | -$774 | 0.71% | 48 |
|
|
2020
Q2 | $1.17M | Sell |
7,101
-90
| -1% | -$13.8K | 0.86% | 40 |
|
|
2020
Q1 | $998K | Buy |
7,191
+105
| +1% | +$14.4K | 0.87% | 37 |
|
|
2019
Q4 | $932K | Buy |
7,086
+174
| +3% | +$20.2K | 0.68% | 47 |
|
|
2019
Q3 | $773K | Buy |
6,912
+555
| +9% | +$61.8K | 0.63% | 48 |
|
|
2019
Q2 | $704K | Buy |
6,357
+425
| +7% | +$50K | 0.6% | 49 |
|
|
2019
Q1 | $770K | Sell |
5,932
-75
| -1% | -$9.12K | 0.68% | 42 |
|
|
2018
Q4 | $695K | Buy |
6,007
+460
| +8% | +$51.4K | 0.68% | 43 |
|
|
2018
Q3 | $595K | Sell |
5,547
-140
| -2% | -$14K | 0.52% | 54 |
|
|
2018
Q2 | $485K | Buy |
5,687
+527
| +10% | +$43.3K | 0.44% | 58 |
|
|
2018
Q1 | $399K | Buy |
5,160
+170
| +3% | +$13.7K | 0.38% | 64 |
|
|
2017
Q4 | $421K | Buy |
4,990
+540
| +12% | +$45.9K | 0.4% | 64 |
|
|
2017
Q3 | $381K | Buy |
4,450
+570
| +15% | +$46.8K | 0.37% | 67 |
|
|
2017
Q2 | $319K | Buy |
3,880
+385
| +11% | +$31.4K | 0.31% | 74 |
|
|
2017
Q1 | $294K | Sell |
3,495
-40
| -1% | -$3.2K | 0.3% | 77 |
|
|
2016
Q4 | $260K | Buy |
+3,535
| New | +$263K | 0.24% | 85 |
|
Other funds holding LLY
Norway Savings Bank's LLY Position: Q2 2026 in Review
Norway Savings Bank reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $630K and leaving 4,469 shares worth $5.36M. The position accounts for 2.25% of the portfolio, ranked #11.
Norway Savings Bank first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.62M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Norway Savings Bank held 4,469 shares of Eli Lilly worth $5.36M as of Q2 2026.
- Norway Savings Bank sold 617 Eli Lilly shares in Q2 2026, an estimated $630K.
- Eli Lilly made up 2.25% of Norway Savings Bank's portfolio in Q2 2026, its #11 holding.
- Norway Savings Bank first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
- Norway Savings Bank's Eli Lilly position peaked at $5.62M in Q4 2025.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.